Just Released: "Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018"

Sept. 28, 2011 - PRLog -- Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, "Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Herpes Simplex Therapeutics market. The report identifies the key trends shaping and driving the global Herpes Simplex Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Herpes Simplex Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/228217_herpes_simplex_therapeu...
------------------------------------------------------------

Scope

The report provides information on the key drivers and challenges of the Herpes Simplex Therapeutics market. Its scope includes -

* Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Herpes Simplex Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
* Analysis of the current and future competition in the seven key countries Herpes Simplex Therapeutics market.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Herpes Simplex Therapeutics market.
* Analysis of key recent licensing and partnership agreements in Herpes Simplex Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Herpes Simplex Therapeutics market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Herpes Simplex Therapeutics market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Herpes Simplex Therapeutics market landscape? - Identify, understand and capitalize.


Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Herpes Simplex: Introduction
2.1 Overview
2.2 Epidemiology
2.3 Etiology
2.4 Clinical Presentation/Symptoms
2.4.1 Signs and Symptoms of Genital Herpes
2.4.2 Signs and Symptoms of Oral Herpes
2.5 Prognosis
2.6 Diagnosis
2.6.1 Clinical Examination
2.7 Pathophysiology
2.8 Treatment
2.9 Prevention
2.10 GlobalData Pipeline Report Guidance
3 Herpes Simplex Therapeutics Market: Market Characterization
3.1 Herpes Simplex Therapeutics Market Size
3.2 Herpes Simplex Therapeutics Market Forecast and CAGR
3.3 Herpes Simplex Market Size (2005-2010) - The US
3.4 Herpes Simplex Market Forecast (2010-2018) - The US
3.5 Herpes Simplex Market Size (2005-2010) - France
3.6 Herpes Simplex Market Forecast (2010-2018) - France
3.7 Herpes Simplex Market Size (2005-2010) - Germany
3.8 Herpes Simplex Market Forecast (2010-2018) - Germany
3.9 Herpes Simplex Market Size (2005-2010) - Italy
3.10 Herpes Simplex Market Forecast (2010-2018) - Italy
3.11 Herpes Simplex Market Size (2005-2010) - Spain
3.12 Herpes Simplex Market Forecast (2010-2018) - Spain
3.13 Herpes Simplex Market Size (2005-2010) - The UK
3.14 Herpes Simplex Market Forecast (2010-2018) - The UK
3.15 Herpes Simplex Market Size (2005-2010) - Japan
3.16 Herpes Simplex Market Forecast (2010-2018) - Japan
3.17 Drivers and Barriers for the Herpes Simplex Therapeutics Market
3.17.1 Drivers for the Herpes Simplex Therapeutics Market
3.17.2 Barriers for the Herpes Simplex Therapeutics Market
3.18 Opportunity and Unmet Need
3.19 Key Takeaway
4 Herpes Simplex Therapeutics Market: Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Portfolio for Major Marketed Products in the Herpes Simplex Therapeutics Market
4.3.1 Zovirax (Acyclovir)
4.3.2 Famvir (Famciclovir)
4.3.3 Valtrex (Valacyclovir)
4.3.4 Denavir (pencyclovir)
4.3.5 Abreva/Erazaban (docasonol)
4.3.6 Xerese/Lipsovir (Acyclovir 5% + Hydrocortisone 1%)
4.4 Key Takeaway
5 Herpes Simplex: Pipeline Assessment
5.1 Overview
5.1.1 Herpes Simplex Therapeutics - Phase III Clinical Pipeline
5.1.2 Herpes Simplex Therapeutics - Phase II Clinical Pipeline

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=2282...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.